Nama Insights

Abbott Laboratories (ABT)

Healthcare · Medical Devices · NYSE

S&P 500
Abbott Laboratories (ABT) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $179.42B, a trailing price-to-earnings ratio of 19.7 and a free-cash-flow yield of 4.1%. Over the most recent reported fiscal year, revenue grew 5.7% and free cash flow per share grew 16.4%.
Market cap$179.42B
Trailing P/E19.7
FCF yield4.1%
Revenue growth (YoY)+5.7%
EPS growth (YoY)+10.3%
FCF/share growth (YoY)+16.4%
ExchangeNYSE
SectorHealthcare
IndustryMedical Devices
Explore live ABT data on Nama Insights →

Recent Congressional trades

Abbott Laboratories trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Richard W. Allen House Sell $15,001 - $50,000 Aug 18, 2026
Richard Dean Dr McCormick House Sell $1,001 - $15,000 Aug 14, 2026
Mike Kelly House Sell $1,001 - $15,000 Aug 12, 2026
Alan Armstrong Senate Sell $15,001 - $50,000 Jul 21, 2026
Alan Armstrong Senate Sell $15,001 - $50,000 Jul 21, 2026
Rick Larsen House Sell $1,001 - $15,000 Jul 12, 2026
Richard Dean Dr McCormick House Buy $1,001 - $15,000 Jul 9, 2026
Gilbert Cisneros House Buy $1,001 - $15,000 Jul 2, 2026
Julie Johnson House Sell $1,001 - $15,000 Jun 12, 2026
Gilbert Cisneros House Sell $1,001 - $15,000 Jun 8, 2026
Richard W. Allen House Sell $15,001 - $50,000 Jun 5, 2026
Josh Gottheimer House Sell $1,001 - $15,000 Jun 3, 2026